Covance Six Sigma Drug Development

Covance discusses company performance and its value from Six Sigma in the drug development process. ...

... "strategic acquisitions such as Swiss Pharma contract, which enhance our integrated drug development capabilities and help us speed development for clients and the expansion of six sigma, including projects with clients, which help us reduce variation and improve the productivity of drug development. " ...

Via Covance: Earnings Call

Incremental Profitability Through Six Sigma

Joe Herring, Chairman and Chief Executive Officer of Covance, offers his perspective on the company's strong performance. ...

... "Our relentless focus on operational and service excellence continues to deliver substantial benefits. Six Sigma, which is being utilized across more than two-thirds of the company, delivered approximately $5 million in incremental profitability in the first half of 2007. More importantly, Six Sigma reduces process variation, which improves project delivery, increases client satisfaction, and helps drive repeat business. By this time next year, we expect all of Covance's service offerings globally to have deployed Six Sigma. In addition, we continue to make strategic infrastructure investments in facilities, information technology, and talent to support our ability to capitalize on the extremely favorable, long-term outsourcing trend in drug development. " ...

Via Covance: Covance Reports 2Q07 Earnings of $0.64 Per Share